资讯
What is salivary gland cancer? The salivary glands are comprised of both major and minor glands. The major glands are the bilateral parotid glands, submandibular glands and sublingual glands. The ...
Serous otitis media (SOM) is when the eustachian tube does not drain and causes fluid to build up in the middle ear space. The fluid build-up can cause discomfort or muffled hearing. If it doesn't ...
Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 22,946.62 Crore) operating in Pharmaceuticals sector. Gland Pharma Ltd. key Products/Revenue ...
The adrenal glands are two small glands located on top of the kidneys. They produce hormones that help regulate heart rate, blood pressure, the immune system, physical stress response, and other ...
Phaeochromocytomas are rare tumours that start in the inner part of the adrenal gland. This is also called the medulla. They are a type of neuroendocrine tumour. They can happen at any age, but the ...
"This case underscores the rare coexistence of serous cystadenofibroma in one ovary and collision features involving serous and mucinous cysts in the contralateral ovary, a combination scarcely ...
Aishan Shih, RN, MS, Christine Miaskowski, RN, PhD, FAAN, Marylin J. Dodd, RN, PhD, FAAN, Nancy A. Stotts, RN, EdD, FAAN, Laurie MacPhail, PhD, DMD ...
Thyroid nodules are lumps that occur in the thyroid gland in the front of the throat. There may be no symptoms, but people may feel a bump in the neck. Thyroid nodules can be a sign of iodine ...
No signs of recurrence were noted during the follow-up observation period. Iatrogenic parotid sialocele is an uncommon complication usually seen after surgery in and around the parotid gland. The ...
Considering taking supplements to treat central serous retinopathy? Below is a list of common natural remedies used to treat or reduce the symptoms of central serous retinopathy. Follow the links ...
Gland Pharma share price: Revenue from operations fell 10% year-on-year to Rs 1,384 crore. EBITDA increased by 1% year-on-year to Rs 360 crore, with margins improving by 300 basis points to 26%. R&D ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果